Status:
COMPLETED
Assessment of Airway Obstruction in Infants With Lower Respiratory Infections
Lead Sponsor:
Indiana University School of Medicine
Collaborating Sponsors:
Thrasher Research Fund
Conditions:
Bronchiolitis
Respiratory Syncytial Virus Infections
Eligibility:
All Genders
2-2 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate how two different aerosol medications may improve airway function in infants with respiratory illness. We are using two different medications and comparing the...
Detailed Description
We hypothesize that VEGF production is higher in children with RSV infection than in children with other viral infections and normal controls. In addition, the degree of VEGF production is related to ...
Eligibility Criteria
Inclusion
- Group 1 Infants between 2 and 24 months that are healthy
- Group 2 Infants between 2 and 24 months that have RSV or bronchiolitis and defined as the first episode of wheezing
Exclusion
- Group 1 and 2 - no cardiac disease, no oxygen requirement, prematurity \< 37 weeks, and cannot be in the ICU.
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00435994
Start Date
December 1 2003
End Date
December 1 2012
Last Update
June 1 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riley Hospital for Children
Indianapolis, Indiana, United States, 46202